Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Plos Neglected Tropical Diseases|March 31, 2021
The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infectionZhiyuan Yao, Fabio Zanini, Sathish Kumar, et al.
Cell Reports|February 14, 2019
MARCH8 Ubiquitinates the Hepatitis C Virus Nonstructural 2 Protein and Mediates Viral EnvelopmentSathish Kumar, Rina Barouch-Bentov, Fei Xiao, et al.
Antiviral Research|November 2, 2020
BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antiviralsSzuyuan Pu, Stanford Schor, Marwah Karim, et al.
European Journal of Medicinal Chemistry|October 20, 2024
Synthesis of 3-heteroaryl-pyrrolo[2,3-b]pyridines as potent inhibitors of AP-2-associated protein kinase 1 (AAK1) with antiviral activityNitha Panikkassery Ravi, Wout Van Eynde, Marwah Karim, et al.
European Journal of Medicinal Chemistry|August 13, 2025
Discovery of antivirally active inhibitors of adaptor protein-2 associated kinase 1 based on various bicyclic heteroaromatic scaffolds derived from a 7-azaindole analogueStijn Anthonissen, Wout Van Eynde, Marwah Karim, et al.
Plos One|June 30, 2010
Connective tissue growth factor in regulation of RhoA mediated cytoskeletal tension associated osteogenesis of mouse adipose-derived stromal cellsYue Xu, Diane R Wagner, Elena Bekerman, et al.
Mbio|March 15, 2018
Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus ReleaseFei Xiao, Stanley Wang, Rina Barouch-Bentov, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2020
Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infectionElena Bekerman, Stephanie Cox, Darius Babusis, et al.
The Journal of Clinical Investigation|June 29, 2023
Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque modelElena Bekerman, Stephen R Yant, Laurie VanderVeen, et al.
Frontiers in Chemistry|May 25, 2026
Synthesis, structure-activity relationships, and SARS-CoV-2 antiviral activity of 3,5-disubstituted isothiazolo[4,3-<i>b</i>]pyridines as PIKfyve inhibitorsLing-Jie Gao, Demian Kalebic, Chieh Wen Lo, et al.
Pageof 9